A. Adem received his Ph.D. degree from Uppsala University in pharmacology in 1987. Following a postdoctoral training at the Institute Pasteur (Paris, France), CNRS (Nogent-sur-Marne, France), and Karolinska Institute (Stockholm, Sweden), Professor Adem was accepted an Assistant Professor's at the Karolinska Institute, Sweden in 1991. In 1994, while still at the Karolinska Institute, he was promoted to the rank of Associate Professor, and in 1999 he moved to UAE to join the Department of Pharmacology and Therapeutics, Faculty of Medicine and Health Sciences (FMHS) at UAE University in Al Ain as a Full Professor. Professor Adem’s long-term goal has been to develop a vigorous functional neuroscience research, education, and training program. The main focus of his research has been neurodegeneration and neurodegenerative disorders like Alzheimer's disease. In order to understand the mechanisms involved in neurodegenerative diseases, his laboratory has been using human tissues as well as different animal models. A combination of molecular, biochemical, morphological, pharmacological, and behavioral approaches has been employed to elucidate the underlying mechanisms which may prove helpful in drug design and discovery. Some of these efforts have led to the discovery of selective ligands for muscarinic receptors. Another aspect of his research has been towards understanding the biology of diabetes and its complications especially in the light that between 24 and 28% of the UAE population suffers from diabetes. His current studies on neurodegeneration and diabetes have been published in journals of international repute. Professor Adem is a Member of the editorial board of a number of journals and works as an Ad Hoc Reviewer for several national and international journals.
Biography Updated on 4 September 2011